Ribavirin: Evaluation of the effects on reproduction, recommendation for classification

In the present report the Health Council of the Netherlands reviewed ribavirin. Ribavirin is an antiviral drug, active against DNA and RNA viruses. This report is part of a series, in which the Health Council evaluates the effects of substances on reproduction, at request of the Minister of Social affairs and Employment. It mainly concerns substances to which man can be occupationally exposed.

Committee

• A.H. Piersma, Professor in Reproductive toxicology, National Institute of Public Health and the Environment, Bilthoven, chairman
• H.F.P. Joosten, Toxicologist, Formerly NV Organon, Department of Toxicology and Drug Disposition, Oss
• D. Lindhout, Professor of Medical Genetics, paediatrician, University Medical Centre, Utrecht
• N. Roeleveld, Epidemiologist, University Medical Centre St Radboud, Nijmegen
• J.G. van Vliet, Reproductive toxicologist, Schering-Plough, Toxicology and Drug disposition, Oss
• D.H. Waalkens-Berendsen, Reproductive toxicologist, TNO Nutrition and Food Research, Zeist
• P.J.J.M. Weterings, Toxicologist, Weterings Consultancy BV, Rosmalen
• A.S.A.M. van der Burght, Health Council of the Netherlands, Den Haag, scientific secretary
• H. Stouten, Health Council of the Netherlands, Den Haag, scientific secretary